Baseline characteristics

Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma · Source last updated 2026-05-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      16

   2. group Id

      BG001

      value

      14

   3. group Id

      BG002

      value

      30

   units

   Participants

groups

1. description

   0.2 mg/Kg every 4 weeks by intravenous route over 1 hour, for 6 or up to 12 cycles

   id

   BG000

   title

   IPH2101 0.2 mg/kg

2. description

   2 mg/Kg every 4 weeks by intravenous route over 1 hour, for 6 or up to 12 cycles

   id

   BG001

   title

   IPH2101 2 mg/kg

3. description

   Total of all reporting groups

   id

   BG002

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            0

         2. group Id

            BG001

            value

            0

         3. group Id

            BG002

            value

            0

         title

         <=18 years

      2. measurements

         1. group Id

            BG000

            value

            10

         2. group Id

            BG001

            value

            11

         3. group Id

            BG002

            value

            21

         title

         Between 18 and 65 years

      3. measurements

         1. group Id

            BG000

            value

            6

         2. group Id

            BG001

            value

            3

         3. group Id

            BG002

            value

            9

         title

         >=65 years

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Age, Categorical

   unit Of Measure

   Participants

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            7.62

            value

            63.6

         2. group Id

            BG001

            spread

            13.11

            value

            58.4

         3. group Id

            BG002

            spread

            10.69

            value

            61.2

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   years

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            9

         2. group Id

            BG001

            value

            4

         3. group Id

            BG002

            value

            13

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            7

         2. group Id

            BG001

            value

            10

         3. group Id

            BG002

            value

            17

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

4. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            16

         2. group Id

            BG001

            value

            14

         3. group Id

            BG002

            value

            30

      title

      United States

   param Type

   NUMBER

   title

   Region of Enrollment

   unit Of Measure

   participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice